Agonist trigger: What is the best approach? Agonist trigger and low dose hCG

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages 529-530

  Humaidan, Peter ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

GnRH antagonist; GnRHa; hCG; OHSS; ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; FIBROBLAST GROWTH FACTOR 2; LUTEINIZING HORMONE RECEPTOR; VASCULOTROPIN A;

COMPETITIVE INHIBITION; DISEASE SEVERITY; DRUG DOSE COMPARISON; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOW DRUG DOSE; LUTEAL PHASE; NEGATIVE FEEDBACK; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; STEROIDOGENESIS; SUPPLEMENTATION; UPREGULATION;

EID: 84857792787     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.11.016     Document Type: Article

References (23)

1. P. Humaidan, H. Ejdrup Bredkjær, L. Bungum, M. Bungum, M.L. Grøndahl, and L.G. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study Hum Reprod 20 2005 1213 1220
2. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. Van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
3. R.G. Edwards, P.C. Steptoe, and J.M. Purdy Establishing full-term human pregnancies using cleaving embryos grown in vitro Br J Obstet Gynaecol 87 1980 737 756
4. S.M. Rosenberg, A.A. Luciano, and D.H. Riddick The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone Fertil Steril 34 1980 17 20
5. H.M. Fatemi The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online 19 Suppl 4 2009 4331
6. B.C. Fauser, and P. Devroey Reproductive biology and IVF: ovarian stimulation and luteal phase consequences Trends Endocrinol Metab 14 2003 236 242
7. A. Tavaniotou, C. Albano, J. Smitz, and P. Devroey Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix Hum Reprod 4 2001 663 667
8. A. Tavaniotou, and P. Devroey Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles Reprod Biomed Online 3 2006 326 330
9. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of GnRH agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
10. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil Steril 56 1991 213 220
11. R.F. Casper, and S.S. Yen Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor Science 205 4404 1979 408 410
12. P. Licht, V. Russu, and L. Wildt On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation Semin Reprod Med 19 2001 37 47
13. C.V. Rao Multiple novel roles of luteinizing hormone Fertil Steril 76 2001 1097 1100
14. N. Sugino, S. Kaskida, S. Takiguchi, A. Karube, and H. Kato Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy J Clin Endocrinol 85 2000 3919 3924
15. J. Tesarik, A. Hazout, and C. Mendoza Luteinizing hormone affects uterine receptivity independently of ovarian function Reprod Biomed Online 7 2003 59 64
16. T.H. Wang, S.G. Horng, Chang, H.M. Wu, Y.J. Tsai, and H.S. Wang Human chorionic gonadotropin-induced hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor J Clin Endocrinol Metab 87 2002 3300 3308
17. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory hCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178
18. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod. Biomed Online 18 2009 630 634
19. P. Humaidan, H.E. Bredkjaer, L.G. Westergaard, and C.Y. Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
20. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
21. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil Steril 95 2011 2715 2717
22. B. Radesic, and K. Tremellen Oocyte maturation employing a GnRH agonist in combination with low dose hCG luteal rescue minimises the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates Hum Reprod 26 2011 3437 3442
23. P. Humaidan, S. Kol, E.G. Papanikolaou Copenhagen GnRH Agonist Triggering Workshop Group GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524